无高氨血症的急性脑病表现不同于显性肝性脑病且预后同样严重
该研究基于前瞻性队列对因急性失代偿住院的肝硬化患者进行回顾性分析,将急性脑病患者按血氨水平分为显性肝性脑病组和无高氨血症脑病组,并设两个无脑病对照组。结果显示无高氨血症脑病占急性脑病的三分之一,预后与显性肝性脑病同样严重;显性肝性脑病与1年无移植生存率降低独立相关。
要点
- 急性脑病患者中69%(168/244)为显性肝性脑病,31%(76/244)为无高氨血症脑病。
- 无高氨血症脑病患者较显性肝性脑病患者更显著暴露于药物。
- 显性肝性脑病与无高氨血症脑病的死亡或移植风险无显著差异(HR 1.27,95%CI 0.91-1.77,p=0.161)。
核心结论
- 无高氨血症脑病占急性脑病入院的三分之一,预后与显性肝性脑病同样严重。
- 显性肝性脑病与1年无移植生存率降低独立相关。
研究设计与样本
- 研究为对因急性失代偿住院患者前瞻性队列的回顾性分析(retrolective analysis)。
- 共纳入530例患者,分为4组:显性肝性脑病组168例、无高氨血症脑病组76例、无脑病且血氨≤50 µmol/L对照组125例、无脑病且血氨>50 µmol/L对照组161例。
- 高氨血症定义为血氨>50 µmol/L。
主要发现
- 急性脑病患者中168/244(69%)为显性肝性脑病,76/244(31%)为无高氨血症脑病。
- 无高氨血症脑病患者较显性肝性脑病患者更显著暴露于药物。
- 1年无移植生存率为60.4%。
- 多变量分析中,与血氨正常且无脑病患者相比,显性肝性脑病与较低的1年无移植生存率独立相关(HR 1.58,95%CI 1.14-2.18,p=0.006)。
- 显性肝性脑病患者死亡或移植风险不高于无高氨血症脑病患者(HR 1.27,95%CI 0.91-1.77,p=0.161)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In cirrhosis, some patients display acute encephalopathy without hyperammonemia (NonHep E) which is not considered as overt hepatic encephalopathy (OHE). We aimed to assess the prevalence and characteristics of NonHep E and OHE in patients with cirrhosis displaying acute encephalopathy, assess their respective prognosis and compare it to other causes of acute decompensation with/without hyperammonemia. APPROACH AND RESULTS: We conducted a retrolective analysis from a prospective cohort of patients hospitalized for acute decompensation. Hyperammonemia was defined by NH3 >50 µmol/L. Patients were divided into 4 groups: OHE (encephalopathy and NH3 >50 µmol/L: group 1), NonHep E (encephalopathy and NH3≤50 µmol/L, group 2), and 2 control groups with acute decompensation/without encephalopathy (NH3≤50 µmol/L [group 3] or NH3>50 µmol/L [group 4]). Five hundred thirty patients were included (168 group 1, 76 group 2, 125 group 3, and 161 group 4). Overall, 168/244 (69%) of patients with acute encephalopathy displayed OHE, and 76/244 (31%) NonHep E. NonHep E patients were significantly more exposed to medications than patients with OHE. One-year transplant-free survival was 60.4%. In multivariable analysis, compared to patients with normal ammonemia and without encephalopathy, OHE was independently associated with a lower 1-year transplant-free survival (1.58 [95% CI: 1.14-2.18, p =0.006]). Patients with OHE did not display a higher risk of death or transplantation than NonHep E patients (HR: 1.27, 95% CI: 0.91-1.77, p =0.161). CONCLUSIONS: NonHep E accounts for one-third of admissions for acute encephalopathy and displays as severe a prognosis as OHE. OHE is independently associated with lower transplant-free survival at 1 year.
引用
- Desplats V, Haudebourg L, Verger N, et al. Acute encephalopathy without hyperammonemia has a different presentation than overt HE and displays a similarly severe prognosis. Hepatology. 2025. PMID: 39879584. doi:10.1097/HEP.0000000000001252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。